Compare SHASUN PHARMA with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs SUN PHARMA - Comparison Results

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA SUN PHARMA SHASUN PHARMA/
SUN PHARMA
 
P/E (TTM) x 123.9 84.7 146.3% View Chart
P/BV x 8.5 3.6 236.2% View Chart
Dividend Yield % 0.2 0.6 39.6%  

Financials

 SHASUN PHARMA   SUN PHARMA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
SUN PHARMA
Mar-20
SHASUN PHARMA/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs94484 19.5%   
Low Rs46315 14.5%   
Sales per share (Unadj.) Rs214.2136.9 156.5%  
Earnings per share (Unadj.) Rs5.317.5 30.6%  
Cash flow per share (Unadj.) Rs15.826.0 60.8%  
Dividends per share (Unadj.) Rs1.004.00 25.0%  
Dividend yield (eoy) %1.41.0 142.9%  
Book value per share (Unadj.) Rs53.3188.7 28.3%  
Shares outstanding (eoy) m56.622,399.26 2.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.32.9 11.2%   
Avg P/E ratio x13.122.9 57.2%  
P/CF ratio (eoy) x4.415.4 28.8%  
Price / Book Value ratio x1.32.1 61.9%  
Dividend payout %18.722.9 81.8%   
Avg Mkt Cap Rs m3,958958,864 0.4%   
No. of employees `000NA17.8 0.0%   
Total wages/salary Rs m2,16463,624 3.4%   
Avg. sales/employee Rs ThNM18,490.6-  
Avg. wages/employee Rs ThNM3,582.6-  
Avg. net profit/employee Rs ThNM2,357.6-  
INCOME DATA
Net Sales Rs m12,127328,375 3.7%  
Other income Rs m2296,360 3.6%   
Total revenues Rs m12,356334,735 3.7%   
Gross profit Rs m1,00969,898 1.4%  
Depreciation Rs m59420,528 2.9%   
Interest Rs m4153,027 13.7%   
Profit before tax Rs m23052,702 0.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-2,606 0.0%   
Tax Rs m-738,228 -0.9%   
Profit after tax Rs m30241,868 0.7%  
Gross profit margin %8.321.3 39.1%  
Effective tax rate %-31.715.6 -202.8%   
Net profit margin %2.512.8 19.5%  
BALANCE SHEET DATA
Current assets Rs m6,884316,542 2.2%   
Current liabilities Rs m8,456157,064 5.4%   
Net working cap to sales %-13.048.6 -26.7%  
Current ratio x0.82.0 40.4%  
Inventory Days Days6288 70.4%  
Debtors Days Days108105 102.7%  
Net fixed assets Rs m4,970243,102 2.0%   
Share capital Rs m1132,399 4.7%   
"Free" reserves Rs m2,875450,245 0.6%   
Net worth Rs m3,020452,645 0.7%   
Long term debt Rs m1,81720,289 9.0%   
Total assets Rs m13,347682,525 2.0%  
Interest coverage x1.618.4 8.4%   
Debt to equity ratio x0.60 1,342.5%  
Sales to assets ratio x0.90.5 188.8%   
Return on assets %5.46.6 81.7%  
Return on equity %10.09.2 108.1%  
Return on capital %13.311.2 118.6%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,84374,219 7.9%   
Fx outflow Rs m2,17327,964 7.8%   
Net fx Rs m3,66946,255 7.9%   
CASH FLOW
From Operations Rs m39865,548 0.6%  
From Investments Rs m-1,635-25,888 6.3%  
From Financial Activity Rs m1,309-57,151 -2.3%  
Net Cashflow Rs m71-13,857 -0.5%  

Share Holding

Indian Promoters % 39.2 63.7 61.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 5.1 70.2%  
FIIs % 17.6 23.0 76.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 8.3 477.1%  
Shareholders   20,750 133,026 15.6%  
Pledged promoter(s) holding % 12.3 0.5 2,318.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   NATCO PHARMA  PANACEA BIOTECH  GLENMARK PHARMA  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare SHASUN PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS